Sep 5, 2022·edited Sep 6, 2022Liked by Alexandros Marinos
In another post I shared how I had followed Dr. Osgood from November 2020 through FDA Horsewormer leading to him falling out with FLCCC and giving up the Ivermectin fight. I'll have to go dig but he had some Tweets that Ivermectin at the very least needs to be in the protocol for regions with parasites so if the case severity gets to the point where steroids are needed it won't carry the same risk. It was nuanced takes like this that made him a key voice to check in on on all things Covid for me for a long time. It was his attitude towards VAERS and vaccine safety that had me ignore guys like Kirsch longer than I should have. But anyways...can't rely on one guy..need to do your work
Given the information in this post alone I can't tell to what degree you've been researching this phenomenon (this is coming from me thinking strongyloidiasis was something related to bodybuilders...) but would it be beneficial to start from the perspective of strongyloidiasis and it's occurrence with corticosteroid use in general first? Like I said I'm not sure to what extent your research has encapsulated the phenomenon but it would be worth the examination of prior history to see if there's associations with acute or chronic use, what comorbidities, etc. and use those associations to glean the situation with COVID.
This page from the CDC mentions a few reports of strongyloidiasis it appears it may use the Pereira, et. al. study you cited so it may be worth looking through the other references:
So basically the steroids are causing the hyperinfection (making the worms stronger?) and possible patient death, and ivermectin is getting thrown under the bus because it’s used to treat the infestation? But the reason for the steroids is because the patient was immunocompromised?
Interestingly I found a PubMed article from 1984 about a hyperinfection in dogs with similar worms…no mention of ivermectin although it was used commercially in veterinary medicine since 1981.
Well that was an interesting read. I'll be childish..icky. So your hypothesis is that perhaps ivm was not as effective in some cases due to dormant worms being activated if treatment included corticosteroids?
Found another one! https://ijmm.ir/browse.php?a_id=1484&sid=1&slc_lang=en&html=1
Added to the sheet
Total now is up to 10
Based on not seeing mexico
https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/4/2/article-CASE21667.xml
In another post I shared how I had followed Dr. Osgood from November 2020 through FDA Horsewormer leading to him falling out with FLCCC and giving up the Ivermectin fight. I'll have to go dig but he had some Tweets that Ivermectin at the very least needs to be in the protocol for regions with parasites so if the case severity gets to the point where steroids are needed it won't carry the same risk. It was nuanced takes like this that made him a key voice to check in on on all things Covid for me for a long time. It was his attitude towards VAERS and vaccine safety that had me ignore guys like Kirsch longer than I should have. But anyways...can't rely on one guy..need to do your work
Given the information in this post alone I can't tell to what degree you've been researching this phenomenon (this is coming from me thinking strongyloidiasis was something related to bodybuilders...) but would it be beneficial to start from the perspective of strongyloidiasis and it's occurrence with corticosteroid use in general first? Like I said I'm not sure to what extent your research has encapsulated the phenomenon but it would be worth the examination of prior history to see if there's associations with acute or chronic use, what comorbidities, etc. and use those associations to glean the situation with COVID.
This page from the CDC mentions a few reports of strongyloidiasis it appears it may use the Pereira, et. al. study you cited so it may be worth looking through the other references:
https://wwwnc.cdc.gov/eid/article/28/7/22-0198-t1#r3
There's also this article looking at migrants and rates of strongyloidiasis in COVID-19 positive migrants:
https://link.springer.com/article/10.1007/s10903-022-01386-w
And this article may be an interesting lead for a review on strongyloidiasis:
https://pubmed.ncbi.nlm.nih.gov/16533536/
Great links! Wow, one article from 2007 said contact with infected soil even 30 years prior was a risk factor!! Scary!
So basically the steroids are causing the hyperinfection (making the worms stronger?) and possible patient death, and ivermectin is getting thrown under the bus because it’s used to treat the infestation? But the reason for the steroids is because the patient was immunocompromised?
Interestingly I found a PubMed article from 1984 about a hyperinfection in dogs with similar worms…no mention of ivermectin although it was used commercially in veterinary medicine since 1981.
https://pubmed.ncbi.nlm.nih.gov/6723900/
Well that was an interesting read. I'll be childish..icky. So your hypothesis is that perhaps ivm was not as effective in some cases due to dormant worms being activated if treatment included corticosteroids?
https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/4/2/article-CASE21667.xml
I don't have much time to do any digging tonight, but this might be helpful.
https://www.ajtmh.org/configurable/content/journals$002ftpmd$002f104$002f3$002farticle-p790.xml?t:ac=journals%24002ftpmd%24002f104%24002f3%24002farticle-p790.xml
Reach out to Jessica Rose. Substack: Unacceptable Jessica.